Nebula Research & Development LLC Buys Shares of 19,363 Henry Schein, Inc. (NASDAQ:HSIC)

Nebula Research & Development LLC acquired a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 19,363 shares of the company's stock, valued at approximately $1,340,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Olstein Capital Management L.P. lifted its stake in Henry Schein by 17.2% in the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock worth $7,543,000 after purchasing an additional 16,000 shares in the last quarter. Private Management Group Inc. raised its holdings in shares of Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock worth $24,256,000 after acquiring an additional 18,882 shares during the period. Equitable Trust Co. acquired a new position in shares of Henry Schein during the 4th quarter valued at about $417,000. Savant Capital LLC grew its holdings in shares of Henry Schein by 43.9% in the fourth quarter. Savant Capital LLC now owns 4,651 shares of the company's stock valued at $322,000 after purchasing an additional 1,420 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in Henry Schein by 29.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock worth $1,113,000 after purchasing an additional 3,650 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently weighed in on HSIC shares. StockNews.com lowered Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Jefferies Financial Group raised their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Barrington Research restated an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Piper Sandler reduced their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday. Finally, UBS Group cut their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein has an average rating of "Moderate Buy" and a consensus price target of $80.20.

Henry Schein Stock Down 0.6 %

NASDAQ:HSIC traded down $0.41 during midday trading on Thursday, hitting $64.57. 367,817 shares of the company were exchanged, compared to its average volume of 1,614,014. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The company has a market capitalization of $7.91 billion, a PE ratio of 26.59, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a fifty day simple moving average of $68.49 and a 200 day simple moving average of $71.68.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.66 EPS. As a group, equities analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.